Open AccessConsumo alimentar de magnésio em pacientes com síndrome metabólica em uso de hidroclorotiazida
Author(s) -
Daniele dos Santos,
Vera Ferreira Andrade de Almeida,
Luana de Oliveira Leite,
Edilene Maria Queiroz Araújo,
Fernando Luís de Queiroz Carvalho,
Domingos Lázaro Souza Rios
Publication year - 2020
Publication title -
braspen journal
Language(s) - English
Resource type - Journals
eISSN - 2764-1546
pISSN - 2525-7374
DOI - 10.37111/braspenj.2020353014
Subject(s) - medicine , hydrochlorothiazide , polypharmacy , magnesium deficiency (plants) , statistical significance , food consumption , family income , magnesium , zoology , environmental health , pediatrics , blood pressure , chemistry , biology , organic chemistry , agricultural economics , economics , economic growth
Hydrochlorothiazide is one of the drugs used to treat systemic arterial hypertension,a component of metabolic syndrome. The use of this medication is related to nutrient losses such asmagnesium, a fact that favors nutritional deficiency for those with inadequate food consumption of thismineral. Thus, this study aimed to assess food intake of magnesium in patients with metabolic syndrome,who use hydrochlorothiazide. Methods: This is a cross-sectional, analytical-descriptive, retrospectivestudy, carried out in a nutrition school clinic in Salvador–BA, in which the evaluation of the magnesiumfood consumption of 35 patients was made, according to the values established by the Dietary Reference Intake, and according to sex, age group, education, family income and polypharmacy therapy.Data analysis was performed considering statistical significance when p-value ≤0.05. Results: Theaverage magnesium food consumption found was 188.02 ± 93.9 mg and the percentage of inadequacyaccording to Estimated Average Requirement and Recommended Dietary Allowances was 80% and85.7%, respectively. The average food consumption revealed higher results for: men (197.22 ± 27.7mg) compared to women (186.83 ± 99.5 mg) (p=0.652); adults aged 20 to 39 years (195.69 ± 139.6mg) compared to other age groups (p=0.935); those who attended high school (205.95 ± 102.5 mg)compared to other schooling (p=0.490); those who had a family income of up to 1 minimum wage(207.06 ± 107.2 mg) compared to other family incomes (p=0.640); and those who used polypharmacy(204.08 ± 104.4 mg) compared to those who did not use it (174.50 ± 84.5 mg) (p=0.371). However,these findings were not statistically significative and all were below the established reference values.Conclusions: The results found revealed an inadequate food intake of magnesium. There is a need toadopt nutritional strategies to encourage the consumption of foods containing magnesium for patientswith metabolic syndromic.